CTNNB1 and hepatocellular carcinoma: In the present study, we have validated these observations and further demonstrated that suppression of miR-214 expression in HCC can modulate the β-catenin signalling pathway by activating CTNNB1 and EZH2 and down-regulating CDH1 expression.